Skip to content

Circles

B

Benitec Biopharma Inc.

BNTC· Nasdaq

B

BNTCBenitec Biopharma Inc.

BNTCBenitec Biopharma Inc.·Earnings record

Q1 2020

Source filing unavailable

Next · Q2 2020

Q1 2020 · —

Revenue

$33.00K

no prior Q1 2019 on file

Net Income

-$1.15M

no prior Q1 2019 on file

EPS Diluted

-$1.34

no prior Q1 2019 on file

Operating Income-$1,166,000—

Operating Cash Flow-$545,000—

Margins · derived

Same quarter

no prior Q1 2019 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Filing lag

Quarterly history

Q1 ’20Q2 ’20 Q3 ’20 Q4 ’20^d Q1 ’21 Q2 ’21 Q3 ’21 Q4 ’21^d Q1 ’22…

Benitec Biopharma Inc. · CIK 1808898 · Engraved from SEC EDGAR

Operating margin

-3533.3%

Net margin-3475.8%

Thaler ResearchEngraved from SEC EDGAR© 2026 Thaler. All rights reserved.Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Platform

Using AI API SDKs CLI

Research

News Listen Earnings Insiders Holders Compare Metrics

Screener Watchlists Pies Notes Your companies

Learn

Thaler

Thaler Agent Promise Provenance Circles Account Terms Privacy